Medli For Life Sciences

A new way to access real-world data.

The field of life sciences is data-intensive, and data is essential for driving research and developing new treatments and cures for diseases. However, obtaining and analysing the necessary data can be a complicated and challenging process.

Medli gives Life Science and Academic Researchers access to anonymised, consented, real world data, in a consistent format across multiple therapeutic areas, in a single platform

Facilitation of patient consent via digital patient information sheets, consent processes and automated data sharing

Targeted discovery of clinical trial candidates, who can record trial data using the app

Medli is the winner of:

New Health Tech Innovation of the Year

What our partners say about Medli…

Pancreatic Cancer UK can make great strides in research and discovery with real-world patient (PROMs) data. Something easily achievable using Medli.

Data analytics for life science companies

Data analytics is crucial for life science companies due to several reasons:

Drug Discovery and Development: Life science companies invest significant resources in discovering and developing new drugs. Data analytics plays a vital role in this process by analysing large datasets to identify patterns and correlations that can guide scientists in identifying potential drug targets, predicting drug efficacy, and optimizing dosage and treatment regimens. It enables the identification of biomarkers, facilitates patient stratification for clinical trials, and enhances the overall efficiency of the drug development pipeline.

Decision Making: Life science companies deal with vast amounts of complex data from various sources such as clinical trials, genomics, patient records, and research studies. Data analytics enables these companies to make informed decisions by extracting valuable insights, identifying trends, and predicting outcomes. It helps them understand the effectiveness of treatments, identify potential drug candidates, and optimize research and development processes.

Precision Medicine: With advancements in genomics and personalised medicine, life science companies can tailor treatments to individual patients based on their genetic makeup, lifestyle, and medical history. Data analytics helps analyse genomic data, patient records, and real-world evidence to identify specific patient subgroups that may respond better to certain treatments. It supports the development of companion diagnostics, improves patient outcomes, and reduces healthcare costs.

Predictive Analytics and Risk Management: Data analytics empowers life science companies to leverage predictive models and risk assessment tools to anticipate potential outcomes and mitigate risks. It enables early detection of adverse events, adverse drug interactions, and safety issues, thereby enhancing patient safety and reducing liabilities. By analysing historical data and real-time information, life science companies can proactively identify risks and take preventive measures.

Market Insights and Commercialisation: Life science companies need to understand market dynamics, patient needs, and competitor landscapes to develop effective commercialisation strategies. Data analytics helps analyse market data, patient demographics, physician prescribing patterns, and sales data to gain insights into market trends, customer behaviour, and product performance. It supports better targeting of customers, pricing strategies, and optimisation of marketing efforts.

Awards & Recognition

  • GDPR Compliant
  • Data securely managed by Amazon Web Services (ISO 27001)
  • Technology based on The Brain Tumour Charity’s BRIAN app
  • Member of the UK Health Data Research Alliance
  • BRIAN is certified by ORCHA as a high-quality medical app
  • BRIAN was commended for good practice by auditors from NHS Digital
  • WINNER of “New Health Tech Innovation of the Year 2023”.